REGIONAL COMPARATIVE ANALYSIS OF LATE COMPLICATIONS AFTER TREATMENT OF COVID-19 DISEASE FROM THE ETIOPATHOGENETIC AND PATHOPHYSIOLOGICAL POINT OF VIEW

Нурбаев, Ф, Мавлянов, И, Хазратов, У, Омонов, О, Олимов, А, Нурбаев, Ф, Мавлянов, И, Хазратов, У, Омонов, О, Олимов, А, Nurbaev, F, Mavlyanov, I, Khazratov, U, Omonov, O, Olimov, A

Тиббиёт ва спорт · 2026-yil

Annotatsiya

According to the World Health Organization (WHO), as of April 2024, the number of people infected with CO VID-19 was 704,753,681, and the death toll reached 7,010,681. When a new coronavirus infection spread around the world in March 2020, WHO declared the situation a pandemic. After the first case of infection was registered in Wuhan, China, a search for ways to stop the spread of severe acute respiratory disease and its treatment began in a short time. In the fight against the new virus, various treatment principles have been repeatedly modified in different countries of the world, but the results have varied. The article provides a comparative analysis of regional aspects of the treatment methods used in the fight against COVID-19 and their long-term complications, and also discusses measures to prevent complications in the fight against the disease.

Maqola ma’lumotlari
MualliflarНурбаев, Ф, Мавлянов, И, Хазратов, У, Омонов, О, Олимов, А, Нурбаев, Ф, Мавлянов, И, Хазратов, У, Омонов, О, Олимов, А, Nurbaev, F, Mavlyanov, I, Khazratov, U, Omonov, O, Olimov, A
JurnalТиббиёт ва спорт
Nashr sanasi2026-06-01
Son1
Betlar42-48
TilO‘zbek

Kalit so‘zlar

COVID-19, нирматрелвир, усиленный ритонавиром, Национальные институты здравоохранения США, инфекция SARS-Cov-2, пандемия, сердечно-сосудистые заболевания, хроническая болезнь почек, диабет, хронические заболевания легких, желудочно-кишечные осложнения, COVID-19, ritonavir-boosted nirmatrelvir, US National Institutes of Health, SARS-Cov-2 infection, pandemic, cardiovascular disease, chronic kidney disease, diabetes, chronic lung disease, gastrointestinal complications, COVID-19, ритонавир-кучайтирилган нирматрелвир, АҚШ Миллий саломатлик институти, SARS-Cov-2 инфекцияси, пандемия, юрак-қон томир касалликлари, сурункали буйрак касаллиги, диабет, ўпканинг сурункали касалликлари, гастроинтестинал асоратлар

Ilmiy soha

Тиббиёт ва спорт jurnalidan boshqa maqolalar

Тиббиёт ва спорт — barcha maqolalar